Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HRS Guidelines Could Improve External Defibrillator Surveillance

This article was originally published in The Gray Sheet

Executive Summary

Companies that make automated external defibrillators should develop systems to track where their devices are stored and who is using them in order to improve recall efforts, say two leading electrocardiologists

You may also be interested in...

Industry And FDA Question Key Heart Rhythm Society Recommendations

Device industry stakeholders do not support a key recommendation from the Heart Rhythm Society that the National Cardiovascular Data Registry be modified to collect more patient follow-up data on the performance of implantable cardioverter defibrillators (ICDs) and pacemakers

Heart Rhythm Society Annual Meeting In Brief

ICD replacement woes?: Mayo Clinic physicians identified nine complications that resulted from 732 implantable cardioverter defibrillator replacement procedures performed at the clinic from 2000 through 2005 in research reported at the Heart Rhythm Society annual meeting May 18 in Boston. The group found that 162 of the replacements were due to recalls and advisories; 570 were elective procedures performed due to expected battery depletions. However, research recently published in the Journal of the American Medical Association and presented at the HRS meeting reported a notably higher complication rate. That study found 43 complications, including 31 requiring re-operation, resulting from 533 ICD replacement procedures performed in 17 Canadian centers between October 2004 and October 2005 (1"The Gray Sheet" May 1, 2006, p. 4). University of Western Ontario Professor Paul Gould, lead author of the latter study, said the observed complication rate "was much higher than we anticipated" and should make physicians think twice before replacing an ICD. Meanwhile, data from a 96-patient survey presented at the meeting by Mount Sinai Medical Center physicians revealed no significant difference in emotional status and overall quality of life between patients with recalled heart devices and devices that had not been recalled...

Civica Rx Gets $55m Investment

Civica Rx has won an investment of $55m through a deal with the Blue Cross Blue Shield Association of US health insurance firms to create a new subsidiary that will acquire and develop generic filings to be launched in the US from 2022.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts